Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: StockHawk who wrote (15999)	3/2/1999 9:25:00 AM
From: Nazbuster	Respond to of 122087

ZONA - I just checked and Dreyfus has it marked "UPC" which means I can't short it... RATS.

To: StockHawk who wrote (15999)	3/2/1999 9:39:00 AM
From: lindend	Read Replies (1) \| Respond to of 122087

clinical trials did not show very good results. Clincical trials showed that sugar & water was equally effective as Vasomax. Sales in Mexico have been poor. Sales in Mexico are non-existant. ZONA had negative sales last Q due to having to refund SGP for promotions etc. If FDA does not approve it could see a big drop. I would say, When the FDA rejects it, ZONA will be sub five. This is sure money if you're willing to be short through July. I'm a little underwater due to the recent run, but I'm not sweating this one.